Phytochemical Characterization and in vitro Evaluation of Antioxidant and Anti α-amylase Activity of Flavonoids and Alkaloids Extracted from Mitracarpus hirtus Leaves

Ousmane Faye¹, Cheikh Sall^1, , Mamadou Soumboundou¹, Awa Ndong^{1, 2}, Mathilde Cabral², Guata Yoro Sy³ and Fatou Bintou Sar¹

¹UMRED, Health Training and Research Unit, University of Iba Der Thiam of Thies, BP 967, Thies, Senegal

²Laboratory of Toxicology and Hydrology, FMPOS, UCAD, PB 5005 Dakar Fann, Senegal

³Laboratory of Pharmacology FMPOS, UCAD, PB 5005 Dakar Fann, Senegal

Cite this paper:
Ousmane Faye, Cheikh Sall, Mamadou Soumboundou, Awa Ndong, Mathilde Cabral, Guata Yoro Sy and Fatou Bintou Sar. Phytochemical Characterization and in vitro Evaluation of Antioxidant and Anti α-amylase Activity of Flavonoids and Alkaloids Extracted from Mitracarpus hirtus Leaves. Journal of Materials Physics and Chemistry. 2022; 10(2):59-64. doi: 10.12691/jmpc-10-2-4

Abstract

Secondary metabolites of medicinal plants constitute a real alternative treatment for diabetes mellitus. They are also sources of natural compounds that could lead to the discovery of new drugs. In this study, the anti-amylase and antioxidant activities of alkaloids and flavonoids extracted from Mitracarpus hirtus leaves were evaluated. DPPH radical and DNS inhibition methods were used for antioxidant activity and anti α-amylase activity, respectively. The results obtained showed that di- and tri-glycoside flavonoids and monoglycosides are the most present with contents of 796 and 522 mg RQE/gES while alkaloids are present at 203 mg RQQ/gES. The DPPH radical inhibitory activity test gives IC₅₀ of 187.99; 236 ug/ml for the di and tri glycosides and monoglycosides flavonoids respectively. Alkaloids show IC₅₀ of 815ug/ml and ascorbic acid used as reference has IC₅₀ of 110 ug/ml. The result of the anti α-amylase activity shows that the monoglycoside flavonoids are more active with an IC₅₀ of 74 ug/ml while the alkaloids have an IC₅₀ of 228 ug/ml. We note that in all the studied parameters, flavonoids are more active than alkaloids. However, the activity of flavonoids is not polarity dependent. The fractions rich in flavonoid mono, di and tri glycosides present rather interesting activities and deserve to be tested in vivo in order to propose them as an alternative treatment for diabetes mellitus.

Keywords:
diabetes Mitracarpus hirtus alkaloids flavonoids

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	O. Faye et al., “Antioxidant and Anti α-amylase Activities of Polar Extracts of Mitracarpus hirtus and Saba senegalensis and the Combinason of their Butanolic Extracts,” Int Res J Pure Appl Chem, no. December, pp. 1-8, 2021.
[2]	Y. J. Kang et al., “Eupatilin, isolated from Artemisia princeps Pampanini, enhances hepatic glucose metabolism and pancreatic β-cell function in type 2 diabetic mice,” Diabetes Res Clin Pract, vol. 82, no. 1, pp. 25032, 2008.
[3]	H. Rasouli, R. Yarani, F. Pociot, and J. Popović-Djordjević, “Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives,” Pharmacol Res, vol. 155, no. February, p. 104723, 2020.
[4]	B. Adhikari, “Roles of Alkaloids from Medicinal Plants in the Management of Diabetes Mellitus,” Journal of Chemistry, vol. 2021. Hindawi Limited, 2021.
[5]	Y. P. Ng, T. C. T. Or, and N. Y. Ip, “Plant alkaloids as drug leads for Alzheimer’s disease,” Neurochem Int, vol. 89, pp. 260-270, 2015.
[6]	J. Kaur, I. Melkani, A. P. Singh, A. P. Singh, and K. Bala, “Galantamine: A Review Update,” Journal of Drug Delivery and Therapeutics, vol. 12, no. 4, pp. 167-173, Jul. 2022.
[7]	L. Messaadia, Y. Bekkar, M. Benamira, and H. Lahmar, “Predicting the antioxidant activity of some flavonoids of Arbutus plant: A theoretical approach,” Chemical Physics Impact, vol. 1, Dec. 2020.
[8]	“Bioactive flavonoids in medicinal plants Structure, activity and biological fate Elsevier Enhanced Reader.”
[9]	J. Chen, S. Mangelinckx, A. Adams, Z. T. Wang, W. L. Li, and N. De Kimpe, “Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications,” Nat Prod Commun, vol. 10, no. 1, pp. 187-200, 2015.
[10]	P. K. Prabhakar, A. Kumar, and M. Doble, “Combination therapy: A new strategy to manage diabetes and its complications,” Phytomedicine, vol. 21, no. 2, pp. 123-130, 2014.
[11]	M. S. Lee, C. C. Chyau, C. P. Wang, T. H. Wang, J. H. Chen, and H. H. Lin, “Flavonoids identification and pancreatic beta-cell protective effect of lotus seedpod,” Antioxidants, vol. 9, no. 8, pp. 1-23, Aug. 2020.
[12]	Z. Fu et al., “Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice,” Endocrinology, vol. 151, no. 7, pp. 3026-3037, 2010.
[13]	J. M. Dias Soares, A. E. B. Pereira Leal, J. C. Silva, J. R. G. S. Almeida, and H. P. de Oliveira, “Influence of flavonoids on mechanism of modulation of insulin secretion,” Pharmacogn Mag, vol. 13, no. 52, pp. 639-646, Oct. 2017.
[14]	I. Saidi, “Caractérisation et valorisation d’une plante de la famille des fabaceae : Gleditsia triacanthos de la région de Sidi Bel Abbès : Extraction des substances bioactives.,” PhD Thesis, pp. 1-188, 2019.
[15]	B. K. Guy, “Sur la Composition Phytochimique Qualitative des Extraits bruts Hydrométhanoliques des Feuilles de 6 Cultivars de Manihot Esculenta Crantz de Côte d ’ Ivoire On the Qualitative Phytochemical Composition of Crude Hydromethanolic extracts of the Leaves of 6,” European Journal of Scientific Research, vol. 45, no. 2, pp. 200-211, 2010.
[16]	P. Dróżdż, V. Šėžienė, and K. Pyrzynska, “Phytochemical Properties and Antioxidant Activities of Extracts from Wild Blueberries and Lingonberries,” Plant Foods for Human Nutrition, vol. 72, no. 4, pp. 360-364, 2017.
[17]	N. Sreevidya and S. Mehrotra, “Spectrophotometric method for estimation of Alkaloids precipitable with dragendorff’s reagent in plant materials,” J AOAC Int, vol. 86, no. 6, pp. 1124–1127, 2003, doi: 10.1093/jaoac/86.6.1124.
[18]	D.-N. Al-Hajj et al., “In Vitro and in Vivo Evaluation of Antidiabetic Activity of Leaf Essential Oil of Pulicaria inuloides-Asteraceae,” Journal of Food and Nutrition Research, vol. 4, no. 7, pp. 461-470, 2016.
[19]	R. S. Gueye, B. Faye, and C. O. Thiam, “Phytochemical Screening, Evaluation of Antioxidant and Anti-sickling Activities of Two Polar Extracts of Combretum glutinosum Leaves. Perr. ex DC,” vol. 19, no. March, pp. 1-11, 2017.
[20]	D. Martirosyan et al., “Study of the effect of gallic acid and cold plasma on the levels of inflammatory factors and antioxidants in the serum sample of subjects with type 2 diabetes mellitus,” Bioact Compd Health Dis, vol. 4, no. 8, pp. 167-179, 2021.
[21]	L. Sun, Y. Wang, and M. Miao, “Inhibition of α-amylase by polyphenolic compounds: Substrate digestion, binding interactions and nutritional intervention,” Trends in Food Science and Technology, vol. 104. Elsevier Ltd, pp. 190-207, Oct. 01, 2020.
[22]	G. R. Gandhi et al., “Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: A systematic review of in vitro and in vivo studies,” Nutrients, vol. 12, no. 10, pp. 1-32, 2020.
[23]	K. Hanhineva et al., “Impact of dietary polyphenols on carbohydrate metabolism,” International Journal of Molecular Sciences, vol. 11, no. 4. pp. 1365-1402, Apr. 2010.
[24]	K. Takemori, K. Akaho, M. Iwase, M. Okano, and T. Kometani, “Effects of Persimmon Fruit Polyphenols on Postprandial Plasma Glucose Elevation in Rats and Humans,” 2022.
[25]	J. Song et al., “Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose,” Journal of Biological Chemistry, vol. 277, no. 18, pp. 15252-15260, May 2002.
[26]	L. Chen, X. Miao, Z. Peng, J. Wang, and Y. Chen, “The pharmacokinetics and bioavailability of three canthinone alkaloids after administration of Kumu injection to rats,” J Ethnopharmacol, vol. 182, pp. 235-241, 2016.
[27]	G. Gopinath et al., “Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors,” Eur J Med Chem, vol. 124, pp. 750-762, 2016.
[28]	B. Dineshkumar, A. Mitra, and M. Mahadevappa, “Antidiabetic and hypolipidemic effects of mahanimbine (carbazole alkaloid) from Murraya koenigii (rutaceae) leaves,” International Journal of Phytomedicine, vol. 2, no. 1, pp. 22-30, 2010.
[29]	N. J. Morrish, S. Wang, L. K. Stevens, J. H. Fuller, H. Keen, and M. Study, “A9 WHO Cause of death,” pp. 14-21, 2001.